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To assess the prevalence of spontaneous remission in
variant angina, 100 patients with this diagnosis who had
undergone coronary arteriography in the hospital and
a follow-up of at least 1 year were studied. Patients with
coronary bypass surgery or myocardial infarction were
excluded. Remission was diagnosed in 45 of the 100 pa-
tients who had been angina-free and had had no treat-
ment for more than 3 months (mean 18.3). The other
55 patients were receiving medical treatment; 37 had
been angina-free for at least 6 months (mean 22.5) and
angina persisted in 18. The persistent angina group had
a lower prevalence of organic coronary stenoses 70% or
greater: 4 of 18 versus 22 of 45 and 22 of 37 for the other
The clinical course of variant angina is often characterized
by spontaneous variations in the degree of disease activity
0 ,2). Treatment with calcium antagonist drugs usually re-
duces the frequency of variant angina attacks or eliminates
them entirely (3,4). Often symptoms do not recur during
months or years of continuous treatment. Under such cir-
cumstances, the absence of angina can be attributed either
to the effect of treatment or to a concurrent spontaneous
remission of variant angina.
The frequency of spontaneous remission is difficult to
assess from reported data 0.2,5-10) but is an important
factor to consider in deciding when , if ever, to discontinue
treatment in an asymptomatic patient with a history of var-
iant angina . This study was undertaken to assess the prev-
alence of spontaneous remission in a large , consecutive
series of patients with variant angina who were followed
regularly after hospital discharge. A second purpose of the
study was to determine if clinical or angiographic variables
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two groups (p < 0.05), and a longer history of rest angina
before admission. The remission group contained more
patients (17 of 45 versus 4 of 55 [p < 0.001]) whose
attacks had been documented only by provocative test-
ing. Rest angina recurred when calcium antagonist drugs
were discontinued in 15 of 51 instances, within 1 month
in 11 patients and later in 4 patients. Remission was
eventually attained in 35 of the 38 patients in whom these
drugs were stopped.
These results indicate that remission is a frequent
outcome of variant angina. This fact should be consid-
ered in the evaluation of the long-term results of treat-
ment and in the planning of care for an individual patient.
might be useful in predicting the probability of spontaneous
remission for an individual patient.
Methods
Study patients. In this study, the diagnosis of variant
angina was made in patients meeting all of the following
criteria : I) burning or squeezing retrosternal chest pain at
rest; 2) relief of the pain in less than 5 minutes after admin-
istration of sublingual nitroglycerin; 3) ST segment eleva-
tion of at least 0.2 mV not present in the baseline electro-
cardiogram but documented during pain and disappearing
with relief of pain; and 4) no subsequent evidence of myo-
cardial necrosis.
During a recent 5 year period , 168 patients meeting these
diagnostic criteria were hospitalized in our coronary care
unit. Excluded from this study were 68 of these patients for
the following reasons: death 05 patients), myocardial in-
farction (22 patients), coronary bypass surgery (16 patients) ,
coronary angioplasty (6 patients), no coronary arteriography
(5 patients) and lost to follow-up (4 patients). The remaining
100 patients were followed up for at least I year after hos-
pitalization and comprise the study population.
Patient management. During their stay in the coronary
care unit, all study patients underwent continuous electro-
cardiographic monitoring for at least 3 days. A complete
electrocardiogram was recorded during episodes of angina
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at rest. Coronary arteriography was performed by a per-
cutaneous transfemoral approach using preformed catheters
(11) with routine filming of sagittally-angulated views of
the left coronary artery. Patients were not routinely given
nitroglycerin before angiography, but if coronary stenoses
were present, the involved vessels were restudied in multiple
views after the administration of nitroglycerin . Ergonovine
testing was not usually done during coronary arteriography .
An ergonovine test was performed after arteriography in the
coronary care unit according to a defined protocol (12) in
patients with suspected but unproven variant angina. Spon-
taneous variant angina attacks were documented in hospital
in 79 of the 100 study patients. In the remaining 21, angina
at rest occurred infrequently or not at all during hospital-
ization, and variant angina attacks were documented only
after ergonovine provocation.
Nifedipine, diltiazem and verapamil were unavailable
when treatment was begun in the first 24 patients; thus, they
were at first treated with perhexiline maleate (12 patients),
beta-adrenergic blockers (6 patients) or long-acting nitrates
alone (6 patients) and later switched to the newer calcium
antagonists. Initial treatment in the remaining 76 patients
was nifedipine (35 patients), diltiazem (16 patients), vera-
pamil (17 patients) or a combination of nifedipine and dil-
tiazem (6 patients). Two patients with poor compliance or
adverse effects took no drug regularly . When angina was
not controlled with one calcium antagonist, an oral, topical
or sublingual long-acting nitrate was added or a different
calcium antagonist was substituted or added.
Follow-up. After discharge, each patient returned to a
special hospital clinic at 1 month, 3 months and every 3
months thereafter. At each visit, a standardized question-
naire , physical examination and electrocardiogram were re-
corded. Attempts to taper or discontinue treatment were
considered in consenting patients with no serious ventricular
arrhythmias or conduction disturbances documented during
variant angina attacks (13) and with no episodes of angina
for at least 6 months. Treatment was discontinued sooner
in four patients with intolerable drug-induced symptoms.
On 43 occasions in 35 patients , drugs were stopped for 24
to 48 hours and an ergonovine test was repeated to assess
the degree of disease activity and the need for continued
treatment (8).
Data analysis. The patients were divided into three
groups . Remission was arbitrarily defined as the absence of
both angina at rest and all treatment for longer than 3 months
(remission group). The second group consisted of patients
who were angina-free for at least 6 months. but who were
still taking calcium antagonist drugs . Patients with persistent
angina, even if it was infrequent, were placed in the third
group (persistent angina group) . Effort angina without rest
angina occurred in only seven patients; all had severe or-
ganic coronary stenoses and all were in the remission group.
Intergroup differences were assessed using an analysis of
variance, a chi-square test or an unpaired t test when
appropriate.
Results
Of the 100 study patients. 45 were completely free of
rest angina and off all treatment for longer than 3 months ;
thus, they comprised the remission group. Of the remaining
55 patients , 37 were still taking calcium antagonist drugs
but had been angina-free for at least 6 months. Angina
persisted in 18 patients.
Clinical Features
The clinical and angiographic features of the three groups
are listed in Table J. The age. sex, site of ST segment
elevation and duration of follow-up study are similar among
all three groups. The persistent angina group is characterized
by a longer duration of rest angina before hospital admission
(12.7 ± 19.9 months compared with 5.3 ± 10.0 and 4.8
± 7.8 months, respectively, for the other two groups) (prob-
ability [p] < 0.05) . In addition , patients with persistent
angina were more likely to have had normal or near normal
coronary arteriograms than were patients in the other two
groups: 14 (78%) of the 18 had no organic stenoses of 70%
or greater versus 23 (5 1%) of 45 in the remission group and
15 (41%) of 37 in the group without angina on treatment
(p < 0.05).
Ergonovine testing. In 21 of the 100 study patients,
angina attacks in hospital were documented only by ergo-
novine provocation. These patients comprised 38% (17 of
45) of the remission group, 3% (I of 37) of the group without
angina on treatment and 17% (3 of 18) of the persistent
angina group (p < 0.001). Stated differently, remission
occurred in 17 of the 21 patients whose attacks were so
infrequentthat they could be documented only by provocation.
Drug treatment. The drugs used for treatment were
similar in the three groups. Nifedipine, diltiazem or vera-
pamil were employed as initial treatment in 64% (29 of 45)
of patients in the remission group , 84% (31 of 37) in the
group without angina on treatment and 78% (14 of 18) in
the persistent angina group (p = not significant).
Duration of follow-up and remission. The mean du-
ration of follow-up in the remission group was 35.5 months
(range 12 to 77). These patients had been treated for a mean
of 13.8 months (range 0 to 50) and had been angina-free
for a mean of 25.9 months (range 3 to 59); 24 of the 45
had no angina after hospital discharge. The mean duration
of remission was 18.3 months (range 3 to 56) . In the group
without angina on treatment. the duration of follow-up was
28.0 months (range 12 to 64) (not statistically different).
These patients had been angina-free for a mean of 22.5
months (range 6 to 48).
For patients in the group without angina on therapy,
treatment either masked remission or completely prevented
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Table I. Clinical and Angiographic Features of the Three Groups
Angina-Free
Rerm ssron on Treatment
Number of patients 45 37
Age (yr) 52± 9 52::9
Sex (male/female) 25/20 29/8
Angina pre-admission (rno) 5.3 ± 10.0 4 8 ± 7.8
Coronary arteriography
No ste MS'S ?'lQ'lp 23 is
Qa I. .t; 13 r~'
Multivesseldisease , 3
Variant angina attacks
Spontaneous 28 36
Provoked only 17* I
Anterior 24 23
Inferior 21 14
Duration of treatment (rno) 13 O± 13 1 28 O± 136
Duration of follow-up (mo) 35.5 ± 23.4 28.0 ± 13.6
Months since last attack 25.9± 14. 1 22.5 :: 12 2
Dur at ion of remission (mo ) 18.3 ±1 4 2
*Sigmficantly different from the other two groups NS = not SIgnificant; p = probabi lity .
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Persistent
Angina
18
46 ± 8
12/6
I2.7 ±1 9 9*
14*
4
o
15
3
9
9
27 5± 14.9
27 5 ± 14 9
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p Value
NS
NS
< 0.05
< 0.05
< 0 001
NS
NS
NS
angina. If treatment was withdrawn, these patients could
have been reclassified to either the remission or persistent
angina group. In 15 of the 37 patients in this group, angina
recurred when an attempt was made during the follow-up
period to decrease or discontinue treatment; thus, in these
patients treatment may still be preventing attacks. On the
other hand, in 18 of the 37 patients, treatment has been
tapered (1 2 patients) or discontinued for less than 3 months
(6 patients) without a recurrence of angina.
The duration of fo llow-up influenced the prevalence of
remission . Remission was present in 16 (33%) of the 48
patients followed up from I to 2 years, compared with 29
(56%) of the 52 followed up for longer than 2 years (p <
0.05). Among the patients followed up for I to 2 years, 21
(44%) were angina-free on treatment and I I (23%) had
persistent angina. Among the patients followed up for longer
than 2 years, 16 (31% ) were angina-free on treatment and
7 (13%) had persistent angina. Thus, the increase in re-
missions with longer follow-up occurs because fewer pa-
tients are being treated and because fewer have angina.
Stopping Treatment
Recur rence of rest angina . In 38 patients who were
receiving calcium antagonists, all treatment was discontin-
ued. Rest angina recurred in 12 (32%) of the 38 patients,
within I month in 8 patients and after an angina-free interval
of greater than I month in 4 patients. Treatment was dis-
continued more than once in several of these patients and
eventually 35 (92%) of the 38 attained remission. Overall.
in 51 patients in whom all treatment was discontinued, rest
angina recurred 15 times (29%); within I month in I I pa-
tients and later in 4 patients. The late recurrences were at
3, 4, 6 and II months.
Ergonovine testing . As previously described (8), er-
gonovine testing was performed 24 to 48 hours after stop-
ping treatment in some patients to assess disease activity
and the need for continued therapy. Eight patients were
tested on two different occasions. Ergonovine provoked an-
gina and ST segment shifts in 22 of 43 tests, and in these
instances treatment was continued. When treatment was
discontinued after the 21negative tests (20 patients), angina
recurred in 6 patients (29%), within I month in 2 patients
and later in 4 patients. Thus, angina occurred as often after
stopping treatment when an ergonovine test was done as
when it was not (6 129%) of 21 patients versus 9 [30%) of
30 patients). Although angina recurred within I month after
stopping treatment more frequently when an ergonovine test
was not done (9 [30%I of 30 patients versus 2 [10%) of 21
patients), this difference was not statistically significant.
Symptomatic versus asymptomatic group. The 12 pa-
tients whose angina recurred when treatment was stopped
differed from the 26 who remained asymptomatic. After
hospital discharge. rest angina had occurred in ) I of the 12
patients with recurrence compared with only 6 of the 26
patients who remained asymptomatic (p < 0.01). The du-
ration of rest angina after discharge was longer in the re-
currence group (1 3.8 ± 12.2 months versus l.6 ± 3.4
months [p < 0.00 IJ). Ten of the 12 patients with recurrence
had no coronary stenoses 70% or greater, compared with
12 of 26 patients who remained asymptomatic (p = 0.07).
Thus, although only I patient was in both groups. the 12
patients with recurrent angina after treatment was stopped
and the J8 patients with persistent angina shared similar
characteristics: a longer duration of angina and a greater
likelihood of no coronary stenoses 70% or greater.
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Discussion
Incidence of remission of rest angina. This study dem-
onstrates that remission is a very frequent outcome in pa-
tients with variant angina. Among 100 patients followed up
for at least I year after hospital discharge, nearly half were
off all treatment and completely free of rest angina , and an
additional third were asymptomatic on treatment. Myo-
cardial infarction usually eliminates attacks of variant angina
(1,14) ; however, patients with this complication were ex-
cluded from the study .
Previous studies have noted that remissions of variant
angina occur, but these have been limited by small numbers
of study patients or short follow-up periods . In three of the
patients described by Prinzmetal et at. (I) , attacks gradually
disappeared without the occurrence of myocardial infarc-
tion; this improvement was attributed to the development
of collateral circulation. Rest angina disappeared in 7 of 10
medically treated patients reported by MacAlpin et at. (2);
the follow-up period ranged from I '12 to more than 5 years
and in only I patient was myocardial infarction the cause
of remission . Heupler (7) described 30 patients with symp-
tomatic coronary artery spasm and nearly normal coronary
arteriograms; spontaneous remission of angina for at least
I month occurred in 17 of these patients. Among the six
patients with perioperative coronary spasm reported on by
Buxton et at. (9), five of five remained angina-free when
nifedipine was stopped and an ergonovine test was negative
in four of five. Severi et al. (15) followed up 120 medically
treated patients with variant angina for 2 to 8 years; myo-
cardial infarction occurred during the first month in 28 pa-
tients and after I month in four patients. The frequency of
spontaneous remission could not be determined in this study
because all patients were treated with verapamil or long-
acting nitrates , or both; however, symptoms decreased in
all but 14 cases, and by the end of 4 years half of the patients
had been angina-free for at least I year.
Limitation of study. A limitation of these and our own
studies is that the disappearance of angina was a subjective
end point not confirmed by objective evidence. It is often
difficult to show that intermittent myocardial ischemia is
present , and probably imposs ible to prove that it is absent.
Active variant angina is frequentl y accompan ied by asymp-
tomatic attacks (16); however, in our experience, 24 hour
Holter recordings in asymptomatic patients either on treat-
ment (17) or after discontinuing treatment almost never re-
veal transient ST segment abnormalities, particularly if an-
gina has not been reported for months. Provocative testing
provides an alternate method for assessing disease activity
in asymptomatic patients during follow-up study (8,9), but
may not be more helpful than a clinical evaluation of symp-
toms. The management of an asymptomatic patient is un-
likely to be influenced by the result of an ergonovine test.
A negative ergonovine test and the absence of angina dem-
onstrate that the disease is either quiescent or controlled by
treatment , but provides no guarantee that symptoms will
not recur in the future.
A second limitation of this study is that the prevalence
of remission could not be defined in a third of the study
population who were asymptomat ic on treatment. Attempts
to taper or discontinue medication suggested that treatment
was preventing rest angina in approximately half of this
subgroup, but that the other half would likely be in remission
if treatment was stopped.
Causes of remission. The cause of spontaneous coro-
nary spasm is unknown and thus the reason why some pa-
tients develop remission is also unknown. The occurrence
of remission in this study did not correlate with the type of
medical treatment employed . Patients with infrequent spon-
taneous attacks of angina , in whom the diagnosis could only
be confirmed with ergonovine testing, usually developed
remission. Compared with patient s with remission, patient s
with persistent angina during follow-up study had had an-
gina for a longer period of time before hospitalization. More
surprisingly, the patients with persistent angina were more
likely to have no organic lesions 70% or greater; that is ,
remission was more common in patients with organic ste-
nosis. This difference could be artifactual. Patients with
severe spasm who also had organic lesions may have been
more susceptible to early myocardi al infarction or death,
leading to their exclusion from the study , while those with
more severe spasm and nearly normal coronary arteriograms
may have had fewer complications but a more prolonged
course. The higher prevalence of death or infarction in our
patient s with organic lesions (described elsewhere [18]) sup-
ports this possibility. Although the results of coro~a~ ar-
teriography and the duration of angina differed statistically
among the remission group compared with those with per-
sistent angina , overlap between the groups limits the clinical
utility of these data .
Stopping treatment. In this study, rest angina recurred
after 15of 51 attempts to discontinue treatment with calcium
antagoni st drugs. Of the 15 recurrences, II occurred within
I month and 4 within I year; however, recurrences have
been reported after asymptomatic intervals of up to 20 years
(5). Eventuall y, remission was attained in 35 of the 38
patients in whom attempts were made to stop treatment.
Patients with recurrent angina after treatment was stopped
had had rest angina for a longer period during treatment and
were more likely to have had nearly normal coronary ar-
teriograms than were patients without angina after treatment
was stopped.
Systematic attempts to stop calcium antagonist drugs in
patients with coronary spasm have been reported. In one
study (19), 37 patients with nearly normal coronary arter-
iograms were treated with verapamil and after a mean of 15
months (range I to 55) , 26 treatment withdrawals were
attempted in hospital. Angina recurred within 48 hours in
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10 cases . Treatment was resumed in all but six patients,
five of whom remained angina -free. Schick et al. (10) en-
tered 38 patients with vasospastic angina treated with ni-
fedipine into a randomized , placebo-controlled withdrawal
study. Most patients had fewer attacks of angina during the
placebo phase compared with the period before nifedipine
treatment, and 4 of 19 patients were entirely angina-free.
In addition to the risk ofrecurrent angina , stopping treat-
ment may also entail a slight risk of myocardial infarction
or sudden death. One patient in the study of Schick et al.
( 10) probably developed a nontransmural infarction after
withdrawal of nifedipine. Myocardial infarction occurred in
one of our patients with variant angina 2 weeks after per-
hexiline maleate was discontinued (20), and in another when
the dose of nifedipine was decreased. To our knowledge,
complications have not been reported after stopping vera-
pamil or diltiazem; in fact, a "carry-over" beneficial effect
has been noted after stopping diltiazem (21). To determine
whether myocardial infarction is coincidental or related to
stopping treatment requires further investigation. The risk
of sudden death is higher in patients with ventricular ar-
rhythmias or conduction disturbances during variant angina
attacks (13); the risk of discontinuing their treatment is
probably also greater.
Clinical implications. Typical angina pectoris is a
symptom of advanced organic coronary artery disease (22) .
Remission of new angina uncomplicated by other manifes-
tations of coronary disease was reported in 32% of men and
44% of women in the Framingham study (23). However,
angina accompanied by objective evidence of myocardial
ischemia almost always persists unless eliminated by treat-
ment or myocardial infarction, because the underlying cause,
severe coronary artery disease , persists.
In contrast, variant angina should be thought of as a
temporary condition . Although it usually occurs in associ-
ation with organic coronary lesions , its clinical manifesta-
tions are caused by coronary spasm. Complications of var-
iant angina are almost entirel y limited to the initial phase
of the disease (13-16) , and this study indicates that symp-
toms usually disappear. The cause of spontaneous coronary
spasm and the reason why it often disappears are unknown.
The fact that many patients are asymptomatic without treat-
ment within I to 5 years after diagnosis should be considered
in the evaluation of the long-term results of treatment and
in the planning of care for an individual patient. Thus , drug
therapy can probably be discontinued at some point in most
patients with a history of variant angina . In patients without
life-threatening arrhythmias during attacks of angina, we
usually begin to taper and discontinue treatment 6 to 12
months after angina disappears .
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